◆Professor Keishi Inoue of the Department of Urology, School of Medicine, has received the "IJU Top Cited Article Award of the Year 2019."
Release Date:
Professor Keishi Inoue of the Department of Urology in the School of Medicine has received the “IJU Top Cited Article Award of the Year 2019.”
This award is presented to the corresponding author of the most highly cited paper published in the *International Journal of Urology* (the official publication of the Japanese Urological Association and the Urological Association of Asia).
Photodynamic therapy using 5-aminolevulinic acid is a treatment that excites the fluorescent compound protoporphyrin IX—which accumulates specifically in cancer cells—using red or green visible light, thereby generating reactive oxygen species that damage the cancer cells. This is a minimally invasive, low-risk treatment that is localized to the cancer and has minimal impact on surrounding healthy cells and tissues.Furthermore, this treatment is painless; localized lesions are treated at low energy levels, and unlike radiation therapy, it can be administered repeatedly, so anesthesia is not required. Consequently, it is expected to become a new, minimally invasive treatment based on a concept entirely different from existing therapies.
For more details on the article, here
The Department of Urology, School of Medicine website is here:
The Affiliated Phototherapy Center website is here